Global Perspectives on Advanced Squamous Cell Carcinoma of the Head and Neck 2022

Global clinical experts discuss perspectives on current treatment strategies and emerging therapies in advanced squamous cell carcinoma of the head and neck

October 26, 2022
Purchase Report

FACULTY CHAIR

Ezra Cohen, MD, FRCPSC, FASCO

UC San Diego Health, San Diego, CA, USA

Faculty Members

Andreas Dietz, MD, PhD
University Hospital of Leipzig, Germany

Kevin Harrington, BSc, MBBS, MRCP, FRCR, FRCP, PhD, DIC
The Institute of Cancer Research, London, United Kingdom

Robert Ferris, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Maura Gillison, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA

Tanguy Seiwert , MD
John Hopkins School of Medicine, Baltimore, MD, USA

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Current Immune-Based Approaches
  • Immune Checkpoint Inhibitors: Relapsed/Metastatic
  • Immune Checkpoint Therapy Optimization
  • Targeted Therapies, Alone or in Combination
  • Other Approaches (including investigational IOs)

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.